Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes.
Dok ('downstream-of-kinase') family of cytoplasmic proteins play a role in signalling downstream of receptor and non-receptor phosphotyrosine kinases. Recently, a skeletal muscle receptor tyrosine kinase (MuSK)-interacting cytoplasmic protein termed Dok-7 has been identified. Subsequently,...
Հիմնական հեղինակներ: | Müller, J, Herczegfalvi, A, Vilchez, J, Colomer, J, Bachinski, L, Mihaylova, V, Santos, M, Schara, U, Deschauer, M, Shevell, M, Poulin, C, Dias, A, Soudo, A, Hietala, M, Aärimaa, T, Krahe, R, Karcagi, V, Huebner, A, Beeson, D, Abicht, A, Lochmüller, H |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
2007
|
Նմանատիպ նյութեր
-
DOK7 congenital myasthenic syndrome.
: Palace, J
Հրապարակվել է: (2012) -
CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
: Müller, J, և այլն
Հրապարակվել է: (2006) -
Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
: Lashley, D, և այլն
Հրապարակվել է: (2010) -
Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
: Burke, G, և այլն
Հրապարակվել է: (2013) -
Dok-7/MuSK signaling and a congenital myasthenic syndrome.
: Yamanashi, Y, և այլն
Հրապարակվել է: (2008)